Illustrations represent an EASI-75 response. See DUPIXENT clinical study responses. Individual patient responses may vary.

Navigating coverage for DUPIXENT

There are many resources available for your patients to gain access to DUPIXENT. This information will help you ensure coverage for your patients.

Resources for You and Your Patients

The following list of documents may help you when enrolling in DUPIXENT MyWay® and submitting prior authorizations (PAs) and appeals for DUPIXENT.


*The letters provide examples of information that may be provided when responding to an insurance company; it is not intended to substitute for or to influence the independent medical judgment of physicians.

How was uncontrolled moderate-to-severe atopic dermatitis in adult patients defined in the clinical trials?

See Frequently Asked Questions
Request a Field Representative Visit Need to connect with a DUPIXENT Field
Representative regarding product-related questions?
Contact a Rep